Summary
The FDA, under the Trump administration, approved a generic version of the abortion pill mifepristone. This decision was quickly criticized by conservative lawmakers who are concerned about the pill’s safety and oppose its use.
Key Facts
- The FDA approved a generic version of mifepristone, an abortion drug.
- Evita Solution's generic version received approval for distribution.
- Conservative lawmakers have criticized the approval, citing safety concerns.
- Senator Josh Hawley expressed disbelief and safety concerns after the approval.
- Representative Mark Harris also questioned the timing of the approval.
- The government shutdown has delayed FDA responses to comments.
- Critics argue that the FDA should have completed a safety review before approval.
